Targeted immune stimulation for more effective vaccines
Cutanos, a spin-off from the Max Planck Society, is developing novel vaccines and immunotherapies
06-Jul-2021 -
In the future, it could be possible to stimulate the immune system with extremely high efficacy via the skin. Cutanos GmbH, a spin-off from the Max Planck Institute of Colloids and Interfaces, has developed a corresponding method for modulating immune cells in the skin. The LC-TDS technology ...
drug delivery
financing
immunotherapies
+2